Another IL-2 variant with decreased binding to high affinity IL-2Rα but increased binding to intermediate affinity IL-2Rβ showed the augmentation of intratumoral CD8/Treg ratio and efficacy in melanoma and colon carcinoma models [128]. This evidence concerns the gene IL2 and colon carcinoma.